IRVINE, CA -- (MARKET WIRE) -- April 11, 2007 -- HealthSonix, Inc. (PINKSHEETS: HSXI) (FRANKFURT: H7S) announced that it is working closely with a number of major pharmaceutical companies, with a view to expand clinical claims and to address the guidelines published by the American College of Rheumatology in the treatment of patients with osteo and rheumatoid arthritis.
